| abstract |
Pharmaceutical preparations for topical, i.e. dermal, application that contain as active ingredient a compound of the formula I <IMAGE> (I) especially 2-hydroxy-5-[(RS)-1-hydroxy-2-[[(RS)-1-(p-methoxyphenyl)-prop-2-yl]-am ino]-ethyl]-formanilide (formoterol), or one of its pharmaceutically acceptable salts, especially its semifumarate, are proposed for the treatment of inflammatory skin diseases. |